# Meloxicam

## Mobicam 15mg

##### 

| TAH Drug Code      | [OMOBI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMOBI)                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Painful osteoarthritis, rheumatoid arthritis, ankylosing spondylitis.                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Adults: maximum:15mg/day Osteoarthritis: 7.5mg/day, the dose can be increased to 15mg/day if needed Rheumatoid arthritis: 15mg/day, can be reduced to 7.5mg/day based on clinical response. Ankylosing Spondylitis (AS):15mg/day Patients who are more likely to have adverse reactions: Should start from 7.5mg/day Severe renal failure: Don't exceed 7.5mg/day Children: Data has not been established.                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity to NSAIDs or aspirin. Active peptic ulceration, severe hepatic insufficiency, non-dialysed severe renal insufficiency. Children < 15 years. Pregnancy & lactation.                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Dyspepsia, nausea, vomiting, abdominal pain, constipation, flatulence, diarrhoea, anaemia, pruritus, rash, lightheadedness, headache, oedema. Cardiovascular: Edema (0.6% to 4.5% ) Gastrointestinal: Abdominal pain (1.9% to 4.7% ), Constipation (0.8% to 2.6% ), Diarrhea (1.9% to 7.8% ), Flatulence (3.2% ), Indigestion (3.8% to 9.5% ), Nausea (2.4% to 7.2% ), Vomiting Neurologic: Dizziness (1.1% to 3.8% ), Headache (2.4% to 8.3% ) Respiratory: Upper respiratory infection (up to 8.3% ) Other: Fever |
| Pregnancy          | Human Data Suggest Risk in 1st and 3Rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

